PBE vs. PPH ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to Market Vectors Pharmaceutical ETF (PPH)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$65.29
Average Daily Volume
11,251
30
PPH
Market Vectors Pharmaceutical ETF
PPH Description
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.Grade (RS Rating)
Last Trade
$90.61
Average Daily Volume
145,682
23
Performance
Period | PBE | PPH |
---|---|---|
30 Days | 9.33% | 6.07% |
60 Days | 0.39% | 1.51% |
90 Days | 2.22% | 2.13% |
12 Months | 4.64% | 16.86% |
0 Overlapping Holdings
Symbol | Grade | Weight in PBE | Weight in PPH | Overlap |
---|
PBE Overweight 30 Positions Relative to PPH
Symbol | Grade | Weight | |
---|---|---|---|
TECH | B | 5.8% | |
AMGN | B | 5.47% | |
NBIX | C | 5.27% | |
BIIB | C | 5.17% | |
VRTX | C | 5.16% | |
REGN | C | 5.04% | |
GILD | F | 4.64% | |
BMRN | F | 4.28% | |
TGTX | C | 3.54% | |
PTCT | C | 3.52% | |
MNKD | D | 3.43% | |
UTHR | B | 3.41% | |
HALO | B | 3.39% | |
CPRX | C | 3.19% | |
BPMC | B | 3.14% | |
QGEN | B | 2.89% | |
COLL | D | 2.82% | |
MYGN | A | 2.81% | |
CLDX | D | 2.79% | |
EXEL | F | 2.76% | |
VCEL | B | 2.58% | |
VCYT | D | 2.51% | |
DVAX | F | 2.47% | |
ITCI | C | 2.43% | |
RGEN | D | 2.3% | |
IONS | F | 2.28% | |
XENE | D | 2.24% | |
FOLD | F | 1.86% | |
ACAD | F | 1.61% | |
EYPT | F | 1.21% |
PBE Underweight 23 Positions Relative to PPH
Symbol | Grade | Weight | |
---|---|---|---|
LLY | C | -11.7% | |
NVO | C | -9.73% | |
JNJ | D | -6.55% | |
MRK | B | -6.22% | |
AZN | A | -5.86% | |
ABBV | D | -5.57% | |
NVS | B | -5.02% | |
MCK | A | -4.81% | |
GSK | A | -4.72% | |
PFE | C | -4.71% | |
SNY | B | -4.57% | |
HLN | C | -4.57% | |
ZTS | D | -4.25% | |
TAK | F | -4.03% | |
BMY | F | -3.69% | |
TEVA | A | -3.25% | |
VTRS | D | -1.71% | |
ELAN | C | -1.0% | |
JAZZ | F | -0.99% | |
CTLT | D | -0.92% | |
OGN | B | -0.68% | |
PRGO | D | -0.6% | |
PDCO | F | -0.3% |
PBE: Top Represented Industries & Keywords
PPH: Top Represented Industries & Keywords